nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—uterine cancer—ovarian cancer	0.4	1	CtDrD
Progesterone—PGR—ovarian cancer	0.0898	0.353	CbGaD
Progesterone—CYP1B1—ovarian cancer	0.0839	0.33	CbGaD
Progesterone—ESR1—ovarian cancer	0.0567	0.223	CbGaD
Progesterone—SLC22A3—Melphalan—ovarian cancer	0.0515	0.239	CbGbCtD
Progesterone—ABCB1—ovarian cancer	0.0241	0.0946	CbGaD
Progesterone—CYP1B1—Paclitaxel—ovarian cancer	0.0162	0.0753	CbGbCtD
Progesterone—ABCB11—Paclitaxel—ovarian cancer	0.0162	0.0753	CbGbCtD
Progesterone—CYP1B1—Docetaxel—ovarian cancer	0.0117	0.0545	CbGbCtD
Progesterone—ABCC1—Epirubicin—ovarian cancer	0.0117	0.0543	CbGbCtD
Progesterone—ABCC1—Paclitaxel—ovarian cancer	0.0115	0.0535	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—ovarian cancer	0.00875	0.0406	CbGbCtD
Progesterone—ABCB11—Doxorubicin—ovarian cancer	0.00875	0.0406	CbGbCtD
Progesterone—ABCC1—Docetaxel—ovarian cancer	0.00834	0.0387	CbGbCtD
Progesterone—ABCC1—Doxorubicin—ovarian cancer	0.00622	0.0288	CbGbCtD
Progesterone—CYP3A7—Paclitaxel—ovarian cancer	0.0057	0.0264	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0057	0.0264	CbGbCtD
Progesterone—ABCB1—Topotecan—ovarian cancer	0.00562	0.0261	CbGbCtD
Progesterone—CYP3A5—Paclitaxel—ovarian cancer	0.00428	0.0198	CbGbCtD
Progesterone—CYP3A7—Docetaxel—ovarian cancer	0.00412	0.0191	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00412	0.0191	CbGbCtD
Progesterone—CYP2C8—Paclitaxel—ovarian cancer	0.00411	0.0191	CbGbCtD
Progesterone—ABCB1—Vinorelbine—ovarian cancer	0.00396	0.0184	CbGbCtD
Progesterone—CYP2D6—Vinorelbine—ovarian cancer	0.00373	0.0173	CbGbCtD
Progesterone—CYP3A4—Topotecan—ovarian cancer	0.00337	0.0156	CbGbCtD
Progesterone—CYP17A1—ovarian follicle—ovarian cancer	0.00316	0.0918	CbGeAlD
Progesterone—CYP3A5—Docetaxel—ovarian cancer	0.00309	0.0143	CbGbCtD
Progesterone—CYP2C9—Paclitaxel—ovarian cancer	0.00287	0.0133	CbGbCtD
Progesterone—ABCB1—Paclitaxel—ovarian cancer	0.00278	0.0129	CbGbCtD
Progesterone—PGR—corpus luteum—ovarian cancer	0.00272	0.0788	CbGeAlD
Progesterone—CYP3A4—Vinorelbine—ovarian cancer	0.00237	0.011	CbGbCtD
Progesterone—PGR—ovarian follicle—ovarian cancer	0.00212	0.0616	CbGeAlD
Progesterone—ABCB1—Docetaxel—ovarian cancer	0.00201	0.00933	CbGbCtD
Progesterone—CYP3A4—Paclitaxel—ovarian cancer	0.00167	0.00774	CbGbCtD
Progesterone—ESR1—ovarian follicle—ovarian cancer	0.00166	0.0482	CbGeAlD
Progesterone—ABCB1—Doxorubicin—ovarian cancer	0.0015	0.00696	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—ovarian cancer	0.00141	0.00656	CbGbCtD
Progesterone—CYP3A4—Docetaxel—ovarian cancer	0.00121	0.00559	CbGbCtD
Progesterone—PGR—oviduct—ovarian cancer	0.000933	0.0271	CbGeAlD
Progesterone—CYP3A4—Doxorubicin—ovarian cancer	0.000899	0.00417	CbGbCtD
Progesterone—AR—oviduct—ovarian cancer	0.000743	0.0216	CbGeAlD
Progesterone—ESR1—oviduct—ovarian cancer	0.00073	0.0212	CbGeAlD
Progesterone—SLC10A1—gonad—ovarian cancer	0.000333	0.00967	CbGeAlD
Progesterone—NR3C2—myometrium—ovarian cancer	0.000321	0.00932	CbGeAlD
Progesterone—PGR—myometrium—ovarian cancer	0.000299	0.00866	CbGeAlD
Progesterone—SLC10A1—female reproductive system—ovarian cancer	0.000297	0.00863	CbGeAlD
Progesterone—CYP17A1—gonad—ovarian cancer	0.00029	0.00842	CbGeAlD
Progesterone—SLC22A3—myometrium—ovarian cancer	0.000273	0.00793	CbGeAlD
Progesterone—SIGMAR1—myometrium—ovarian cancer	0.000264	0.00767	CbGeAlD
Progesterone—SLC22A3—embryo—ovarian cancer	0.000263	0.00763	CbGeAlD
Progesterone—OPRK1—female reproductive system—ovarian cancer	0.000262	0.00761	CbGeAlD
Progesterone—Dydrogesterone—PGR—ovarian cancer	0.000262	0.115	CrCbGaD
Progesterone—CYP17A1—female reproductive system—ovarian cancer	0.000259	0.00752	CbGeAlD
Progesterone—NR3C2—uterine cervix—ovarian cancer	0.00025	0.00725	CbGeAlD
Progesterone—SLC10A1—testis—ovarian cancer	0.00024	0.00697	CbGeAlD
Progesterone—AR—myometrium—ovarian cancer	0.000238	0.0069	CbGeAlD
Progesterone—ABCB11—testis—ovarian cancer	0.000237	0.00689	CbGeAlD
Progesterone—CYP17A1—female gonad—ovarian cancer	0.000236	0.00684	CbGeAlD
Progesterone—PGR—epithelium—ovarian cancer	0.000234	0.0068	CbGeAlD
Progesterone—ESR1—myometrium—ovarian cancer	0.000233	0.00678	CbGeAlD
Progesterone—SHBG—endometrium—ovarian cancer	0.000233	0.00677	CbGeAlD
Progesterone—PGR—uterine cervix—ovarian cancer	0.000232	0.00674	CbGeAlD
Progesterone—NR3C2—endometrium—ovarian cancer	0.000226	0.00656	CbGeAlD
Progesterone—ABCC1—myometrium—ovarian cancer	0.000226	0.00656	CbGeAlD
Progesterone—ESR1—embryo—ovarian cancer	0.000225	0.00652	CbGeAlD
Progesterone—PGR—decidua—ovarian cancer	0.000221	0.00642	CbGeAlD
Progesterone—SHBG—gonad—ovarian cancer	0.000216	0.00628	CbGeAlD
Progesterone—Ethynodiol—PGR—ovarian cancer	0.000216	0.0945	CrCbGaD
Progesterone—SHBG—uterus—ovarian cancer	0.000215	0.00624	CbGeAlD
Progesterone—SLC22A3—uterine cervix—ovarian cancer	0.000213	0.00617	CbGeAlD
Progesterone—PGR—endometrium—ovarian cancer	0.00021	0.0061	CbGeAlD
Progesterone—CYP17A1—testis—ovarian cancer	0.000209	0.00607	CbGeAlD
Progesterone—NR3C2—uterus—ovarian cancer	0.000208	0.00605	CbGeAlD
Progesterone—SIGMAR1—uterine cervix—ovarian cancer	0.000206	0.00597	CbGeAlD
Progesterone—SIGMAR1—decidua—ovarian cancer	0.000196	0.00568	CbGeAlD
Progesterone—PGR—uterus—ovarian cancer	0.000194	0.00562	CbGeAlD
Progesterone—SHBG—female reproductive system—ovarian cancer	0.000193	0.00561	CbGeAlD
Progesterone—SLC22A3—endometrium—ovarian cancer	0.000192	0.00558	CbGeAlD
Progesterone—NR3C2—female reproductive system—ovarian cancer	0.000187	0.00543	CbGeAlD
Progesterone—AR—epithelium—ovarian cancer	0.000187	0.00542	CbGeAlD
Progesterone—CYP1B1—decidua—ovarian cancer	0.000186	0.0054	CbGeAlD
Progesterone—SIGMAR1—endometrium—ovarian cancer	0.000186	0.0054	CbGeAlD
Progesterone—AR—uterine cervix—ovarian cancer	0.000185	0.00537	CbGeAlD
Progesterone—Norgestimate—PGR—ovarian cancer	0.000183	0.0803	CrCbGaD
Progesterone—ESR1—epithelium—ovarian cancer	0.000183	0.00532	CbGeAlD
Progesterone—SHBG—bone marrow—ovarian cancer	0.000182	0.00529	CbGeAlD
Progesterone—ESR1—uterine cervix—ovarian cancer	0.000182	0.00527	CbGeAlD
Progesterone—CYP2A6—vagina—ovarian cancer	0.000181	0.00524	CbGeAlD
Progesterone—SLC22A3—gonad—ovarian cancer	0.000178	0.00518	CbGeAlD
Progesterone—AR—decidua—ovarian cancer	0.000176	0.00512	CbGeAlD
Progesterone—SHBG—female gonad—ovarian cancer	0.000176	0.0051	CbGeAlD
Progesterone—ABCC1—uterine cervix—ovarian cancer	0.000176	0.0051	CbGeAlD
Progesterone—SHBG—vagina—ovarian cancer	0.000175	0.00507	CbGeAlD
Progesterone—PGR—female reproductive system—ovarian cancer	0.000174	0.00505	CbGeAlD
Progesterone—ESR1—decidua—ovarian cancer	0.000173	0.00502	CbGeAlD
Progesterone—NR3C1—myometrium—ovarian cancer	0.000172	0.005	CbGeAlD
Progesterone—SIGMAR1—uterus—ovarian cancer	0.000171	0.00497	CbGeAlD
Progesterone—NR3C2—female gonad—ovarian cancer	0.00017	0.00494	CbGeAlD
Progesterone—NR3C2—vagina—ovarian cancer	0.000169	0.00491	CbGeAlD
Progesterone—ABCC1—decidua—ovarian cancer	0.000167	0.00486	CbGeAlD
Progesterone—AR—endometrium—ovarian cancer	0.000167	0.00486	CbGeAlD
Progesterone—NR3C1—embryo—ovarian cancer	0.000166	0.00481	CbGeAlD
Progesterone—ESR1—endometrium—ovarian cancer	0.000164	0.00477	CbGeAlD
Progesterone—CYP1B1—gonad—ovarian cancer	0.000164	0.00476	CbGeAlD
Progesterone—CYP1B1—uterus—ovarian cancer	0.000163	0.00473	CbGeAlD
Progesterone—SLC22A3—female reproductive system—ovarian cancer	0.000159	0.00462	CbGeAlD
Progesterone—ABCC1—endometrium—ovarian cancer	0.000159	0.00461	CbGeAlD
Progesterone—PGR—female gonad—ovarian cancer	0.000158	0.0046	CbGeAlD
Progesterone—Megestrol acetate—PGR—ovarian cancer	0.000158	0.069	CrCbGaD
Progesterone—PGR—vagina—ovarian cancer	0.000157	0.00457	CbGeAlD
Progesterone—SHBG—testis—ovarian cancer	0.000156	0.00453	CbGeAlD
Progesterone—AR—gonad—ovarian cancer	0.000155	0.00451	CbGeAlD
Progesterone—AR—uterus—ovarian cancer	0.000154	0.00448	CbGeAlD
Progesterone—ESR1—gonad—ovarian cancer	0.000152	0.00442	CbGeAlD
Progesterone—CYP17A1—lymph node—ovarian cancer	0.000152	0.0044	CbGeAlD
Progesterone—ESR1—uterus—ovarian cancer	0.000151	0.0044	CbGeAlD
Progesterone—NR3C2—testis—ovarian cancer	0.000151	0.00439	CbGeAlD
Progesterone—SLC22A1—vagina—ovarian cancer	0.000151	0.00438	CbGeAlD
Progesterone—ABCC1—uterus—ovarian cancer	0.000147	0.00425	CbGeAlD
Progesterone—CYP1B1—female reproductive system—ovarian cancer	0.000146	0.00425	CbGeAlD
Progesterone—SIGMAR1—bone marrow—ovarian cancer	0.000145	0.00422	CbGeAlD
Progesterone—SLC22A3—female gonad—ovarian cancer	0.000145	0.00421	CbGeAlD
Progesterone—SLC22A3—vagina—ovarian cancer	0.000144	0.00418	CbGeAlD
Progesterone—PGR—testis—ovarian cancer	0.00014	0.00408	CbGeAlD
Progesterone—SIGMAR1—female gonad—ovarian cancer	0.00014	0.00407	CbGeAlD
Progesterone—CYP1A1—epithelium—ovarian cancer	0.000139	0.00404	CbGeAlD
Progesterone—SIGMAR1—vagina—ovarian cancer	0.000139	0.00404	CbGeAlD
Progesterone—AR—female reproductive system—ovarian cancer	0.000139	0.00402	CbGeAlD
Progesterone—CYP1A1—uterine cervix—ovarian cancer	0.000138	0.00401	CbGeAlD
Progesterone—Drospirenone—PGR—ovarian cancer	0.000138	0.0603	CrCbGaD
Progesterone—Ethynodiol—ESR1—ovarian cancer	0.000136	0.0596	CrCbGaD
Progesterone—ESR1—female reproductive system—ovarian cancer	0.000136	0.00395	CbGeAlD
Progesterone—CYP2C8—endometrium—ovarian cancer	0.000135	0.00393	CbGeAlD
Progesterone—NR3C1—epithelium—ovarian cancer	0.000135	0.00392	CbGeAlD
Progesterone—CYP3A5—uterine cervix—ovarian cancer	0.000135	0.00392	CbGeAlD
Progesterone—NR3C1—uterine cervix—ovarian cancer	0.000134	0.00389	CbGeAlD
Progesterone—CYP1B1—female gonad—ovarian cancer	0.000133	0.00387	CbGeAlD
Progesterone—SLC22A3—testis—ovarian cancer	0.000129	0.00373	CbGeAlD
Progesterone—NR3C1—decidua—ovarian cancer	0.000128	0.00371	CbGeAlD
Progesterone—AR—female gonad—ovarian cancer	0.000126	0.00366	CbGeAlD
Progesterone—AR—vagina—ovarian cancer	0.000125	0.00364	CbGeAlD
Progesterone—Trilostane—ESR1—ovarian cancer	0.000125	0.0549	CrCbGaD
Progesterone—SIGMAR1—testis—ovarian cancer	0.000124	0.00361	CbGeAlD
Progesterone—ESR1—female gonad—ovarian cancer	0.000124	0.0036	CbGeAlD
Progesterone—ESR1—vagina—ovarian cancer	0.000123	0.00357	CbGeAlD
Progesterone—NR3C1—endometrium—ovarian cancer	0.000121	0.00352	CbGeAlD
Progesterone—ABCC1—female gonad—ovarian cancer	0.00012	0.00348	CbGeAlD
Progesterone—ABCC1—vagina—ovarian cancer	0.000119	0.00346	CbGeAlD
Progesterone—CYP1B1—testis—ovarian cancer	0.000118	0.00343	CbGeAlD
Progesterone—CYP2C19—vagina—ovarian cancer	0.000116	0.00337	CbGeAlD
Progesterone—Norgestimate—ESR1—ovarian cancer	0.000116	0.0507	CrCbGaD
Progesterone—CYP1A1—uterus—ovarian cancer	0.000115	0.00334	CbGeAlD
Progesterone—NR3C1—gonad—ovarian cancer	0.000112	0.00326	CbGeAlD
Progesterone—Levonorgestrel—PGR—ovarian cancer	0.000112	0.0492	CrCbGaD
Progesterone—CYP2C8—female reproductive system—ovarian cancer	0.000112	0.00325	CbGeAlD
Progesterone—AR—testis—ovarian cancer	0.000112	0.00325	CbGeAlD
Progesterone—NR3C1—uterus—ovarian cancer	0.000112	0.00324	CbGeAlD
Progesterone—ESR1—testis—ovarian cancer	0.00011	0.00319	CbGeAlD
Progesterone—NR3C2—lymph node—ovarian cancer	0.00011	0.00318	CbGeAlD
Progesterone—ABCC1—testis—ovarian cancer	0.000106	0.00308	CbGeAlD
Progesterone—CYP1A1—female reproductive system—ovarian cancer	0.000104	0.003	CbGeAlD
Progesterone—Danazol—PGR—ovarian cancer	0.000102	0.0448	CrCbGaD
Progesterone—PGR—lymph node—ovarian cancer	0.000102	0.00296	CbGeAlD
Progesterone—CYP2C8—vagina—ovarian cancer	0.000101	0.00294	CbGeAlD
Progesterone—NR3C1—female reproductive system—ovarian cancer	0.0001	0.00291	CbGeAlD
Progesterone—CYP2C9—female reproductive system—ovarian cancer	9.96e-05	0.00289	CbGeAlD
Progesterone—Spironolactone—PGR—ovarian cancer	9.8e-05	0.0429	CrCbGaD
Progesterone—NR3C1—bone marrow—ovarian cancer	9.48e-05	0.00275	CbGeAlD
Progesterone—CYP1A1—female gonad—ovarian cancer	9.42e-05	0.00273	CbGeAlD
Progesterone—CYP1A1—vagina—ovarian cancer	9.36e-05	0.00272	CbGeAlD
Progesterone—SLC22A3—lymph node—ovarian cancer	9.32e-05	0.0027	CbGeAlD
Progesterone—ABCB1—myometrium—ovarian cancer	9.22e-05	0.00268	CbGeAlD
Progesterone—CYP3A5—female gonad—ovarian cancer	9.21e-05	0.00267	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—PGR—ovarian cancer	9.18e-05	0.0402	CrCbGaD
Progesterone—CYP3A5—vagina—ovarian cancer	9.15e-05	0.00266	CbGeAlD
Progesterone—NR3C1—female gonad—ovarian cancer	9.14e-05	0.00265	CbGeAlD
Progesterone—Norethindrone—PGR—ovarian cancer	9.1e-05	0.0398	CrCbGaD
Progesterone—NR3C1—vagina—ovarian cancer	9.08e-05	0.00264	CbGeAlD
Progesterone—CYP2C8—testis—ovarian cancer	9.05e-05	0.00263	CbGeAlD
Progesterone—SIGMAR1—lymph node—ovarian cancer	9.01e-05	0.00261	CbGeAlD
Progesterone—ABCB1—embryo—ovarian cancer	8.87e-05	0.00257	CbGeAlD
Progesterone—CYP1B1—lymph node—ovarian cancer	8.57e-05	0.00249	CbGeAlD
Progesterone—AR—lymph node—ovarian cancer	8.11e-05	0.00235	CbGeAlD
Progesterone—NR3C1—testis—ovarian cancer	8.11e-05	0.00235	CbGeAlD
Progesterone—ESR1—lymph node—ovarian cancer	7.96e-05	0.00231	CbGeAlD
Progesterone—ABCC1—lymph node—ovarian cancer	7.71e-05	0.00224	CbGeAlD
Progesterone—CYP3A4—female reproductive system—ovarian cancer	7.6e-05	0.0022	CbGeAlD
Progesterone—CYP2D6—female reproductive system—ovarian cancer	7.48e-05	0.00217	CbGeAlD
Progesterone—ABCB1—epithelium—ovarian cancer	7.24e-05	0.0021	CbGeAlD
Progesterone—ABCB1—uterine cervix—ovarian cancer	7.18e-05	0.00208	CbGeAlD
Progesterone—Levonorgestrel—ESR1—ovarian cancer	7.09e-05	0.031	CrCbGaD
Progesterone—ABCB1—decidua—ovarian cancer	6.84e-05	0.00198	CbGeAlD
Progesterone—CYP2D6—female gonad—ovarian cancer	6.8e-05	0.00197	CbGeAlD
Progesterone—Fluoxymesterone—ESR1—ovarian cancer	6.75e-05	0.0296	CrCbGaD
Progesterone—ABCB1—endometrium—ovarian cancer	6.49e-05	0.00188	CbGeAlD
Progesterone—Danazol—ESR1—ovarian cancer	6.45e-05	0.0283	CrCbGaD
Progesterone—CYP1A1—lymph node—ovarian cancer	6.06e-05	0.00176	CbGeAlD
Progesterone—CYP2D6—testis—ovarian cancer	6.03e-05	0.00175	CbGeAlD
Progesterone—ABCB1—gonad—ovarian cancer	6.02e-05	0.00175	CbGeAlD
Progesterone—ABCB1—uterus—ovarian cancer	5.98e-05	0.00174	CbGeAlD
Progesterone—NR3C1—lymph node—ovarian cancer	5.88e-05	0.00171	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—ESR1—ovarian cancer	5.79e-05	0.0254	CrCbGaD
Progesterone—ABCB1—female reproductive system—ovarian cancer	5.38e-05	0.00156	CbGeAlD
Progesterone—ABCB1—bone marrow—ovarian cancer	5.08e-05	0.00147	CbGeAlD
Progesterone—ABCB1—female gonad—ovarian cancer	4.89e-05	0.00142	CbGeAlD
Progesterone—ABCB1—vagina—ovarian cancer	4.86e-05	0.00141	CbGeAlD
Progesterone—Testosterone—CYP1B1—ovarian cancer	4.68e-05	0.0205	CrCbGaD
Progesterone—ABCB1—testis—ovarian cancer	4.34e-05	0.00126	CbGeAlD
Progesterone—Megestrol acetate—ABCB1—ovarian cancer	4.23e-05	0.0185	CrCbGaD
Progesterone—Infestation—Epirubicin—ovarian cancer	3.33e-05	0.000538	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—ovarian cancer	3.33e-05	0.000537	CcSEcCtD
Progesterone—Dyspnoea—Paclitaxel—ovarian cancer	3.31e-05	0.000535	CcSEcCtD
Progesterone—Somnolence—Paclitaxel—ovarian cancer	3.3e-05	0.000534	CcSEcCtD
Progesterone—Myalgia—Docetaxel—ovarian cancer	3.29e-05	0.000531	CcSEcCtD
Progesterone—Chest pain—Docetaxel—ovarian cancer	3.29e-05	0.000531	CcSEcCtD
Progesterone—Arthralgia—Docetaxel—ovarian cancer	3.29e-05	0.000531	CcSEcCtD
Progesterone—Nausea—Vinorelbine—ovarian cancer	3.28e-05	0.00053	CcSEcCtD
Progesterone—Dyspepsia—Paclitaxel—ovarian cancer	3.27e-05	0.000528	CcSEcCtD
Progesterone—Neuropathy peripheral—Epirubicin—ovarian cancer	3.27e-05	0.000527	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	3.26e-05	0.000527	CcSEcCtD
Progesterone—Jaundice—Epirubicin—ovarian cancer	3.25e-05	0.000525	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—ovarian cancer	3.24e-05	0.000523	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—ovarian cancer	3.24e-05	0.000523	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—ovarian cancer	3.23e-05	0.000522	CcSEcCtD
Progesterone—Decreased appetite—Paclitaxel—ovarian cancer	3.23e-05	0.000522	CcSEcCtD
Progesterone—Dry mouth—Docetaxel—ovarian cancer	3.21e-05	0.000519	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	3.21e-05	0.000519	CcSEcCtD
Progesterone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	3.21e-05	0.000518	CcSEcCtD
Progesterone—Fatigue—Paclitaxel—ovarian cancer	3.2e-05	0.000518	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—ovarian cancer	3.19e-05	0.000516	CcSEcCtD
Progesterone—Pain—Paclitaxel—ovarian cancer	3.18e-05	0.000513	CcSEcCtD
Progesterone—Constipation—Paclitaxel—ovarian cancer	3.18e-05	0.000513	CcSEcCtD
Progesterone—Confusional state—Docetaxel—ovarian cancer	3.18e-05	0.000513	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—ovarian cancer	3.15e-05	0.000509	CcSEcCtD
Progesterone—Anaphylactic shock—Docetaxel—ovarian cancer	3.15e-05	0.000509	CcSEcCtD
Progesterone—Oedema—Docetaxel—ovarian cancer	3.15e-05	0.000509	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—ovarian cancer	3.15e-05	0.000508	CcSEcCtD
Progesterone—ABCB1—lymph node—ovarian cancer	3.15e-05	0.000913	CbGeAlD
Progesterone—Infection—Docetaxel—ovarian cancer	3.13e-05	0.000505	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—ovarian cancer	3.13e-05	0.000505	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—ovarian cancer	3.13e-05	0.000505	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—ovarian cancer	3.12e-05	0.000504	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—ovarian cancer	3.1e-05	0.000501	CcSEcCtD
Progesterone—Shock—Docetaxel—ovarian cancer	3.1e-05	0.000501	CcSEcCtD
Progesterone—Nervous system disorder—Docetaxel—ovarian cancer	3.09e-05	0.000499	CcSEcCtD
Progesterone—Infestation—Doxorubicin—ovarian cancer	3.08e-05	0.000498	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—ovarian cancer	3.08e-05	0.000498	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—ovarian cancer	3.08e-05	0.000498	CcSEcCtD
Progesterone—Tachycardia—Docetaxel—ovarian cancer	3.07e-05	0.000497	CcSEcCtD
Progesterone—Feeling abnormal—Paclitaxel—ovarian cancer	3.06e-05	0.000495	CcSEcCtD
Progesterone—Skin disorder—Docetaxel—ovarian cancer	3.06e-05	0.000494	CcSEcCtD
Progesterone—Gastrointestinal pain—Paclitaxel—ovarian cancer	3.04e-05	0.000491	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—ovarian cancer	3.02e-05	0.000488	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—ovarian cancer	3.01e-05	0.000486	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—ovarian cancer	3e-05	0.000485	CcSEcCtD
Progesterone—Anorexia—Docetaxel—ovarian cancer	3e-05	0.000485	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—ovarian cancer	3e-05	0.000484	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—ovarian cancer	3e-05	0.000484	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—ovarian cancer	3e-05	0.000484	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—ovarian cancer	2.99e-05	0.000483	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—ovarian cancer	2.99e-05	0.000483	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—ovarian cancer	2.97e-05	0.000479	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—ovarian cancer	2.95e-05	0.000477	CcSEcCtD
Progesterone—Urticaria—Paclitaxel—ovarian cancer	2.95e-05	0.000477	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—ovarian cancer	2.95e-05	0.000476	CcSEcCtD
Progesterone—Hypotension—Docetaxel—ovarian cancer	2.94e-05	0.000475	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—ovarian cancer	2.94e-05	0.000475	CcSEcCtD
Progesterone—Body temperature increased—Paclitaxel—ovarian cancer	2.94e-05	0.000475	CcSEcCtD
Progesterone—Abdominal pain—Paclitaxel—ovarian cancer	2.94e-05	0.000475	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—ovarian cancer	2.93e-05	0.000474	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—ovarian cancer	2.92e-05	0.000471	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—ovarian cancer	2.89e-05	0.000467	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—ovarian cancer	2.88e-05	0.000466	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	2.87e-05	0.000464	CcSEcCtD
Progesterone—Insomnia—Docetaxel—ovarian cancer	2.85e-05	0.00046	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—ovarian cancer	2.83e-05	0.000457	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—ovarian cancer	2.83e-05	0.000457	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—ovarian cancer	2.81e-05	0.000454	CcSEcCtD
Progesterone—Somnolence—Docetaxel—ovarian cancer	2.8e-05	0.000452	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—ovarian cancer	2.8e-05	0.000451	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—ovarian cancer	2.79e-05	0.00045	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—ovarian cancer	2.78e-05	0.000449	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—ovarian cancer	2.78e-05	0.000448	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—ovarian cancer	2.77e-05	0.000448	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—ovarian cancer	2.77e-05	0.000448	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—ovarian cancer	2.77e-05	0.000447	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—ovarian cancer	2.77e-05	0.000447	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—ovarian cancer	2.75e-05	0.000444	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—ovarian cancer	2.74e-05	0.000442	CcSEcCtD
Progesterone—Hypersensitivity—Paclitaxel—ovarian cancer	2.74e-05	0.000442	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—ovarian cancer	2.73e-05	0.000441	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—ovarian cancer	2.73e-05	0.00044	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—ovarian cancer	2.72e-05	0.000439	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—ovarian cancer	2.72e-05	0.000439	CcSEcCtD
Progesterone—Fatigue—Docetaxel—ovarian cancer	2.72e-05	0.000439	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—ovarian cancer	2.71e-05	0.000438	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—ovarian cancer	2.71e-05	0.000438	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—ovarian cancer	2.7e-05	0.000436	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—ovarian cancer	2.7e-05	0.000435	CcSEcCtD
Progesterone—Constipation—Docetaxel—ovarian cancer	2.69e-05	0.000435	CcSEcCtD
Progesterone—Pain—Docetaxel—ovarian cancer	2.69e-05	0.000435	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—ovarian cancer	2.67e-05	0.000431	CcSEcCtD
Progesterone—Asthenia—Paclitaxel—ovarian cancer	2.67e-05	0.000431	CcSEcCtD
Progesterone—Alopecia—Epirubicin—ovarian cancer	2.64e-05	0.000427	CcSEcCtD
Progesterone—Pruritus—Paclitaxel—ovarian cancer	2.63e-05	0.000425	CcSEcCtD
Progesterone—Spironolactone—ABCB1—ovarian cancer	2.63e-05	0.0115	CrCbGaD
Progesterone—Mental disorder—Epirubicin—ovarian cancer	2.62e-05	0.000423	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—ovarian cancer	2.62e-05	0.000423	CcSEcCtD
Progesterone—Erythema—Epirubicin—ovarian cancer	2.6e-05	0.000421	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—ovarian cancer	2.6e-05	0.000421	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—ovarian cancer	2.6e-05	0.000419	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—ovarian cancer	2.59e-05	0.000418	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—ovarian cancer	2.58e-05	0.000417	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—ovarian cancer	2.58e-05	0.000416	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—ovarian cancer	2.57e-05	0.000415	CcSEcCtD
Progesterone—Flatulence—Epirubicin—ovarian cancer	2.57e-05	0.000414	CcSEcCtD
Progesterone—Tension—Epirubicin—ovarian cancer	2.55e-05	0.000413	CcSEcCtD
Progesterone—Diarrhoea—Paclitaxel—ovarian cancer	2.54e-05	0.000411	CcSEcCtD
Progesterone—Nervousness—Epirubicin—ovarian cancer	2.53e-05	0.000408	CcSEcCtD
Progesterone—Back pain—Epirubicin—ovarian cancer	2.52e-05	0.000407	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—ovarian cancer	2.51e-05	0.000406	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—ovarian cancer	2.5e-05	0.000404	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—ovarian cancer	2.5e-05	0.000404	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—ovarian cancer	2.49e-05	0.000403	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—ovarian cancer	2.49e-05	0.000402	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—ovarian cancer	2.49e-05	0.000402	CcSEcCtD
Progesterone—Dizziness—Paclitaxel—ovarian cancer	2.46e-05	0.000397	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—ovarian cancer	2.45e-05	0.000396	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—ovarian cancer	2.45e-05	0.000395	CcSEcCtD
Progesterone—Norethindrone—ABCB1—ovarian cancer	2.44e-05	0.0107	CrCbGaD
Progesterone—Mental disorder—Doxorubicin—ovarian cancer	2.42e-05	0.000392	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—ovarian cancer	2.42e-05	0.00039	CcSEcCtD
Progesterone—Erythema—Doxorubicin—ovarian cancer	2.41e-05	0.000389	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—ovarian cancer	2.41e-05	0.000389	CcSEcCtD
Progesterone—Anaemia—Epirubicin—ovarian cancer	2.41e-05	0.000389	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—ovarian cancer	2.37e-05	0.000383	CcSEcCtD
Progesterone—Tension—Doxorubicin—ovarian cancer	2.36e-05	0.000382	CcSEcCtD
Progesterone—Vomiting—Paclitaxel—ovarian cancer	2.36e-05	0.000382	CcSEcCtD
Progesterone—Malaise—Epirubicin—ovarian cancer	2.35e-05	0.000379	CcSEcCtD
Progesterone—Rash—Paclitaxel—ovarian cancer	2.34e-05	0.000378	CcSEcCtD
Progesterone—Dermatitis—Paclitaxel—ovarian cancer	2.34e-05	0.000378	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—ovarian cancer	2.34e-05	0.000378	CcSEcCtD
Progesterone—Vertigo—Epirubicin—ovarian cancer	2.34e-05	0.000378	CcSEcCtD
Progesterone—Syncope—Epirubicin—ovarian cancer	2.33e-05	0.000377	CcSEcCtD
Progesterone—Back pain—Doxorubicin—ovarian cancer	2.33e-05	0.000376	CcSEcCtD
Progesterone—Headache—Paclitaxel—ovarian cancer	2.33e-05	0.000376	CcSEcCtD
Progesterone—Hypersensitivity—Docetaxel—ovarian cancer	2.32e-05	0.000375	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—ovarian cancer	2.32e-05	0.000374	CcSEcCtD
Progesterone—Palpitations—Epirubicin—ovarian cancer	2.3e-05	0.000372	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—ovarian cancer	2.29e-05	0.00037	CcSEcCtD
Progesterone—Prednisolone—ABCB1—ovarian cancer	2.28e-05	0.00999	CrCbGaD
Progesterone—Cough—Epirubicin—ovarian cancer	2.27e-05	0.000367	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—ovarian cancer	2.27e-05	0.000367	CcSEcCtD
Progesterone—Asthenia—Docetaxel—ovarian cancer	2.26e-05	0.000365	CcSEcCtD
Progesterone—Convulsion—Epirubicin—ovarian cancer	2.26e-05	0.000364	CcSEcCtD
Progesterone—Hypertension—Epirubicin—ovarian cancer	2.25e-05	0.000363	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—ovarian cancer	2.24e-05	0.000361	CcSEcCtD
Progesterone—Pruritus—Docetaxel—ovarian cancer	2.23e-05	0.00036	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—ovarian cancer	2.23e-05	0.00036	CcSEcCtD
Progesterone—Myalgia—Epirubicin—ovarian cancer	2.22e-05	0.000358	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—ovarian cancer	2.22e-05	0.000358	CcSEcCtD
Progesterone—Chest pain—Epirubicin—ovarian cancer	2.22e-05	0.000358	CcSEcCtD
Progesterone—Anxiety—Epirubicin—ovarian cancer	2.21e-05	0.000357	CcSEcCtD
Progesterone—Nausea—Paclitaxel—ovarian cancer	2.21e-05	0.000357	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	2.2e-05	0.000356	CcSEcCtD
Progesterone—Discomfort—Epirubicin—ovarian cancer	2.19e-05	0.000354	CcSEcCtD
Progesterone—Malaise—Doxorubicin—ovarian cancer	2.17e-05	0.000351	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—ovarian cancer	2.17e-05	0.00035	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—ovarian cancer	2.16e-05	0.00035	CcSEcCtD
Progesterone—Syncope—Doxorubicin—ovarian cancer	2.16e-05	0.000349	CcSEcCtD
Progesterone—Diarrhoea—Docetaxel—ovarian cancer	2.16e-05	0.000348	CcSEcCtD
Progesterone—Confusional state—Epirubicin—ovarian cancer	2.14e-05	0.000346	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—ovarian cancer	2.13e-05	0.000344	CcSEcCtD
Progesterone—Oedema—Epirubicin—ovarian cancer	2.12e-05	0.000343	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—ovarian cancer	2.12e-05	0.000343	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—ovarian cancer	2.12e-05	0.000342	CcSEcCtD
Progesterone—Infection—Epirubicin—ovarian cancer	2.11e-05	0.000341	CcSEcCtD
Progesterone—Cough—Doxorubicin—ovarian cancer	2.1e-05	0.00034	CcSEcCtD
Progesterone—Shock—Epirubicin—ovarian cancer	2.09e-05	0.000338	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—ovarian cancer	2.09e-05	0.000337	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—ovarian cancer	2.08e-05	0.000337	CcSEcCtD
Progesterone—Dizziness—Docetaxel—ovarian cancer	2.08e-05	0.000336	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—ovarian cancer	2.08e-05	0.000336	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—ovarian cancer	2.07e-05	0.000335	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—ovarian cancer	2.06e-05	0.000333	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—ovarian cancer	2.05e-05	0.000332	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—ovarian cancer	2.05e-05	0.000331	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—ovarian cancer	2.05e-05	0.000331	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—ovarian cancer	2.05e-05	0.000331	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—ovarian cancer	2.04e-05	0.00033	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	2.04e-05	0.000329	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—ovarian cancer	2.03e-05	0.000327	CcSEcCtD
Progesterone—Anorexia—Epirubicin—ovarian cancer	2.03e-05	0.000327	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—ovarian cancer	2.01e-05	0.000324	CcSEcCtD
Progesterone—Vomiting—Docetaxel—ovarian cancer	2e-05	0.000324	CcSEcCtD
Progesterone—Rash—Docetaxel—ovarian cancer	1.99e-05	0.000321	CcSEcCtD
Progesterone—Hypotension—Epirubicin—ovarian cancer	1.99e-05	0.000321	CcSEcCtD
Progesterone—Dermatitis—Docetaxel—ovarian cancer	1.98e-05	0.000321	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—ovarian cancer	1.98e-05	0.00032	CcSEcCtD
Progesterone—Headache—Docetaxel—ovarian cancer	1.97e-05	0.000319	CcSEcCtD
Progesterone—Oedema—Doxorubicin—ovarian cancer	1.97e-05	0.000318	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—ovarian cancer	1.97e-05	0.000318	CcSEcCtD
Progesterone—Infection—Doxorubicin—ovarian cancer	1.95e-05	0.000315	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.94e-05	0.000313	CcSEcCtD
Progesterone—Shock—Doxorubicin—ovarian cancer	1.93e-05	0.000312	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—ovarian cancer	1.93e-05	0.000311	CcSEcCtD
Progesterone—Insomnia—Epirubicin—ovarian cancer	1.92e-05	0.00031	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—ovarian cancer	1.92e-05	0.00031	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—ovarian cancer	1.91e-05	0.000308	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—ovarian cancer	1.91e-05	0.000308	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—ovarian cancer	1.9e-05	0.000307	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—ovarian cancer	1.89e-05	0.000306	CcSEcCtD
Progesterone—Somnolence—Epirubicin—ovarian cancer	1.89e-05	0.000305	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—ovarian cancer	1.87e-05	0.000303	CcSEcCtD
Progesterone—Nausea—Docetaxel—ovarian cancer	1.87e-05	0.000302	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—ovarian cancer	1.87e-05	0.000302	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—ovarian cancer	1.85e-05	0.000298	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—ovarian cancer	1.84e-05	0.000297	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.83e-05	0.000296	CcSEcCtD
Progesterone—Fatigue—Epirubicin—ovarian cancer	1.83e-05	0.000296	CcSEcCtD
Progesterone—Constipation—Epirubicin—ovarian cancer	1.82e-05	0.000293	CcSEcCtD
Progesterone—Pain—Epirubicin—ovarian cancer	1.82e-05	0.000293	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.79e-05	0.000289	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—ovarian cancer	1.78e-05	0.000287	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—ovarian cancer	1.77e-05	0.000285	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—ovarian cancer	1.75e-05	0.000283	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—ovarian cancer	1.75e-05	0.000283	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—ovarian cancer	1.75e-05	0.000282	CcSEcCtD
Progesterone—Hydrocortisone—ABCB1—ovarian cancer	1.75e-05	0.00764	CrCbGaD
Progesterone—Gastrointestinal pain—Epirubicin—ovarian cancer	1.74e-05	0.000281	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—ovarian cancer	1.73e-05	0.00028	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—ovarian cancer	1.71e-05	0.000276	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.7e-05	0.000274	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—ovarian cancer	1.7e-05	0.000274	CcSEcCtD
Progesterone—Urticaria—Epirubicin—ovarian cancer	1.69e-05	0.000273	CcSEcCtD
Progesterone—Pain—Doxorubicin—ovarian cancer	1.68e-05	0.000272	CcSEcCtD
Progesterone—Constipation—Doxorubicin—ovarian cancer	1.68e-05	0.000272	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—ovarian cancer	1.68e-05	0.000271	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—ovarian cancer	1.68e-05	0.000271	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—ovarian cancer	1.62e-05	0.000262	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.61e-05	0.00026	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—ovarian cancer	1.57e-05	0.000253	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—ovarian cancer	1.56e-05	0.000252	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—ovarian cancer	1.55e-05	0.000251	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—ovarian cancer	1.55e-05	0.000251	CcSEcCtD
Progesterone—Asthenia—Epirubicin—ovarian cancer	1.52e-05	0.000246	CcSEcCtD
Progesterone—Pruritus—Epirubicin—ovarian cancer	1.5e-05	0.000243	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—ovarian cancer	1.45e-05	0.000235	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—ovarian cancer	1.45e-05	0.000234	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—ovarian cancer	1.41e-05	0.000228	CcSEcCtD
Progesterone—Dizziness—Epirubicin—ovarian cancer	1.41e-05	0.000227	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—ovarian cancer	1.39e-05	0.000225	CcSEcCtD
Progesterone—Vomiting—Epirubicin—ovarian cancer	1.35e-05	0.000218	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—ovarian cancer	1.35e-05	0.000217	CcSEcCtD
Progesterone—Testosterone—ABCB1—ovarian cancer	1.34e-05	0.00589	CrCbGaD
Progesterone—Rash—Epirubicin—ovarian cancer	1.34e-05	0.000216	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—ovarian cancer	1.34e-05	0.000216	CcSEcCtD
Progesterone—Headache—Epirubicin—ovarian cancer	1.33e-05	0.000215	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—ovarian cancer	1.3e-05	0.00021	CcSEcCtD
Progesterone—Nausea—Epirubicin—ovarian cancer	1.26e-05	0.000204	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—ovarian cancer	1.25e-05	0.000202	CcSEcCtD
Progesterone—Rash—Doxorubicin—ovarian cancer	1.24e-05	0.0002	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—ovarian cancer	1.24e-05	0.0002	CcSEcCtD
Progesterone—Headache—Doxorubicin—ovarian cancer	1.23e-05	0.000199	CcSEcCtD
Progesterone—Nausea—Doxorubicin—ovarian cancer	1.17e-05	0.000189	CcSEcCtD
Progesterone—CYP1B1—Metabolism—PIK3CD—ovarian cancer	2.2e-06	7.09e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—MAPK3—ovarian cancer	2.19e-06	7.09e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTEN—ovarian cancer	2.19e-06	7.08e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.17e-06	7e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SLC2A1—ovarian cancer	2.16e-06	6.97e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—FASN—ovarian cancer	2.14e-06	6.92e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ABCB1—ovarian cancer	2.13e-06	6.89e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—ovarian cancer	2.13e-06	6.89e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CAV1—ovarian cancer	2.13e-06	6.89e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—FASN—ovarian cancer	2.12e-06	6.86e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.12e-06	6.85e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	2.11e-06	6.81e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.11e-06	6.81e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.1e-06	6.77e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CG—ovarian cancer	2.1e-06	6.77e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TYMS—ovarian cancer	2.1e-06	6.77e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—ovarian cancer	2.09e-06	6.77e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.09e-06	6.75e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1B1—ovarian cancer	2.07e-06	6.69e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.06e-06	6.67e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—ovarian cancer	2.05e-06	6.62e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—ovarian cancer	2.04e-06	6.6e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.03e-06	6.57e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6ST—ovarian cancer	2.02e-06	6.53e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.02e-06	6.52e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB2—ovarian cancer	2.01e-06	6.5e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—ovarian cancer	2e-06	6.46e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CB—ovarian cancer	1.99e-06	6.41e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MTOR—ovarian cancer	1.99e-06	6.41e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CD—ovarian cancer	1.98e-06	6.4e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CB—ovarian cancer	1.98e-06	6.39e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—ovarian cancer	1.98e-06	6.39e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CD—ovarian cancer	1.98e-06	6.39e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.97e-06	6.38e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—ovarian cancer	1.96e-06	6.33e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.96e-06	6.32e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—ovarian cancer	1.95e-06	6.31e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.95e-06	6.3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APC—ovarian cancer	1.94e-06	6.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	1.94e-06	6.27e-05	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—ovarian cancer	1.94e-06	6.27e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.94e-06	6.26e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.93e-06	6.25e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TYMS—ovarian cancer	1.92e-06	6.21e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CB—ovarian cancer	1.91e-06	6.18e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—ovarian cancer	1.91e-06	6.16e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—ovarian cancer	1.9e-06	6.12e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.88e-06	6.08e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK3—ovarian cancer	1.87e-06	6.05e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.87e-06	6.05e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1B—ovarian cancer	1.86e-06	6.02e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—ovarian cancer	1.84e-06	5.95e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CD—ovarian cancer	1.84e-06	5.95e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.84e-06	5.93e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—ovarian cancer	1.83e-06	5.9e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—ovarian cancer	1.83e-06	5.9e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—ovarian cancer	1.82e-06	5.89e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—ovarian cancer	1.82e-06	5.89e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—ovarian cancer	1.82e-06	5.88e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CD—ovarian cancer	1.81e-06	5.86e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—ovarian cancer	1.81e-06	5.86e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—FASN—ovarian cancer	1.81e-06	5.86e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CAV1—ovarian cancer	1.79e-06	5.78e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.78e-06	5.77e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK1—ovarian cancer	1.78e-06	5.75e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—ovarian cancer	1.78e-06	5.75e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—ovarian cancer	1.78e-06	5.74e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—ovarian cancer	1.76e-06	5.69e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.75e-06	5.64e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK3—ovarian cancer	1.74e-06	5.64e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.73e-06	5.59e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CB—ovarian cancer	1.73e-06	5.58e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—ovarian cancer	1.73e-06	5.58e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.72e-06	5.57e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CB—ovarian cancer	1.72e-06	5.57e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.72e-06	5.55e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—ovarian cancer	1.72e-06	5.54e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TYMS—ovarian cancer	1.72e-06	5.54e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.71e-06	5.54e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—ovarian cancer	1.71e-06	5.52e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	1.71e-06	5.51e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.71e-06	5.51e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—ovarian cancer	1.7e-06	5.48e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MAPK3—ovarian cancer	1.69e-06	5.46e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CAV1—ovarian cancer	1.69e-06	5.46e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.69e-06	5.45e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—ovarian cancer	1.68e-06	5.43e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—ovarian cancer	1.67e-06	5.41e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TYMS—ovarian cancer	1.67e-06	5.41e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—ovarian cancer	1.67e-06	5.41e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MAPK3—ovarian cancer	1.66e-06	5.38e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK1—ovarian cancer	1.66e-06	5.36e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—ovarian cancer	1.66e-06	5.36e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—ovarian cancer	1.65e-06	5.34e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.65e-06	5.34e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—ovarian cancer	1.64e-06	5.31e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—ovarian cancer	1.63e-06	5.28e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—ovarian cancer	1.63e-06	5.26e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—ovarian cancer	1.62e-06	5.23e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.61e-06	5.21e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—ovarian cancer	1.61e-06	5.19e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.61e-06	5.19e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—ovarian cancer	1.61e-06	5.19e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.59e-06	5.14e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—ovarian cancer	1.58e-06	5.11e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TYMS—ovarian cancer	1.58e-06	5.1e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—ovarian cancer	1.57e-06	5.07e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TYMS—ovarian cancer	1.56e-06	5.05e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—ovarian cancer	1.55e-06	5.01e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CAV1—ovarian cancer	1.55e-06	5e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—ovarian cancer	1.55e-06	4.99e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—ovarian cancer	1.54e-06	4.97e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—ovarian cancer	1.53e-06	4.96e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—ovarian cancer	1.53e-06	4.95e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—ovarian cancer	1.51e-06	4.87e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—ovarian cancer	1.5e-06	4.83e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—ovarian cancer	1.49e-06	4.82e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—ovarian cancer	1.49e-06	4.81e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MTOR—ovarian cancer	1.49e-06	4.81e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	1.49e-06	4.81e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—ovarian cancer	1.48e-06	4.78e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.48e-06	4.78e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK3—ovarian cancer	1.47e-06	4.74e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.47e-06	4.73e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.46e-06	4.71e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—ovarian cancer	1.44e-06	4.65e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—ovarian cancer	1.43e-06	4.62e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—ovarian cancer	1.43e-06	4.62e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—ovarian cancer	1.43e-06	4.62e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—ovarian cancer	1.43e-06	4.61e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.41e-06	4.56e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—FASN—ovarian cancer	1.4e-06	4.52e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	1.4e-06	4.51e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK1—ovarian cancer	1.39e-06	4.51e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—ovarian cancer	1.39e-06	4.51e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—ovarian cancer	1.39e-06	4.48e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CAV1—ovarian cancer	1.38e-06	4.46e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.38e-06	4.45e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—ovarian cancer	1.37e-06	4.42e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—ovarian cancer	1.37e-06	4.42e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—ovarian cancer	1.37e-06	4.42e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—ovarian cancer	1.37e-06	4.42e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—ovarian cancer	1.37e-06	4.41e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.36e-06	4.4e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—ovarian cancer	1.35e-06	4.37e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CAV1—ovarian cancer	1.35e-06	4.36e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TYMS—ovarian cancer	1.34e-06	4.32e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—ovarian cancer	1.33e-06	4.31e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—ovarian cancer	1.33e-06	4.3e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.33e-06	4.3e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.32e-06	4.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	1.32e-06	4.26e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—ovarian cancer	1.32e-06	4.26e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—ovarian cancer	1.31e-06	4.24e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—ovarian cancer	1.29e-06	4.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—ovarian cancer	1.29e-06	4.15e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—ovarian cancer	1.28e-06	4.12e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.28e-06	4.12e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CAV1—ovarian cancer	1.27e-06	4.11e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—ovarian cancer	1.26e-06	4.08e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CAV1—ovarian cancer	1.26e-06	4.07e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.26e-06	4.07e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—ovarian cancer	1.25e-06	4.03e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.24e-06	4.01e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.23e-06	3.97e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-06	3.91e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—ovarian cancer	1.21e-06	3.9e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.2e-06	3.89e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—ovarian cancer	1.18e-06	3.81e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—ovarian cancer	1.18e-06	3.8e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—ovarian cancer	1.17e-06	3.78e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—ovarian cancer	1.17e-06	3.77e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—ovarian cancer	1.16e-06	3.75e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.16e-06	3.74e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—ovarian cancer	1.15e-06	3.71e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.15e-06	3.71e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—ovarian cancer	1.15e-06	3.71e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—ovarian cancer	1.14e-06	3.68e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.13e-06	3.65e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—ovarian cancer	1.12e-06	3.63e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—ovarian cancer	1.12e-06	3.62e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.11e-06	3.58e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK3—ovarian cancer	1.1e-06	3.55e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.08e-06	3.49e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.08e-06	3.49e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—ovarian cancer	1.08e-06	3.48e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CAV1—ovarian cancer	1.08e-06	3.48e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—ovarian cancer	1.07e-06	3.46e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—ovarian cancer	1.07e-06	3.45e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—ovarian cancer	1.05e-06	3.4e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—ovarian cancer	1.05e-06	3.39e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.05e-06	3.39e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK1—ovarian cancer	1.05e-06	3.38e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—ovarian cancer	1.05e-06	3.38e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TYMS—ovarian cancer	1.03e-06	3.33e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.03e-06	3.32e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—ovarian cancer	1.02e-06	3.29e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.02e-06	3.29e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.01e-06	3.26e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—ovarian cancer	9.89e-07	3.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—ovarian cancer	9.87e-07	3.19e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—ovarian cancer	9.85e-07	3.18e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—ovarian cancer	9.81e-07	3.17e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—ovarian cancer	9.79e-07	3.16e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—ovarian cancer	9.65e-07	3.12e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—ovarian cancer	9.64e-07	3.12e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—ovarian cancer	9.53e-07	3.08e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—ovarian cancer	9.41e-07	3.04e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—ovarian cancer	9.34e-07	3.02e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	9.07e-07	2.93e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—ovarian cancer	8.87e-07	2.87e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	8.79e-07	2.84e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—ovarian cancer	8.77e-07	2.83e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—ovarian cancer	8.62e-07	2.79e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—ovarian cancer	8.6e-07	2.78e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—ovarian cancer	8.58e-07	2.77e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—ovarian cancer	8.39e-07	2.71e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—ovarian cancer	8.33e-07	2.69e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CAV1—ovarian cancer	8.31e-07	2.68e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—ovarian cancer	8.14e-07	2.63e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—ovarian cancer	8.03e-07	2.59e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—ovarian cancer	8e-07	2.58e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—ovarian cancer	7.88e-07	2.55e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—ovarian cancer	7.67e-07	2.48e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—ovarian cancer	7.61e-07	2.46e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—ovarian cancer	7.6e-07	2.46e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	7.57e-07	2.45e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—ovarian cancer	7.52e-07	2.43e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—ovarian cancer	7.41e-07	2.39e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—ovarian cancer	7.19e-07	2.32e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.65e-07	2.15e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	6.59e-07	2.13e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—ovarian cancer	6.49e-07	2.1e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—ovarian cancer	6.21e-07	2.01e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—ovarian cancer	5.88e-07	1.9e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—ovarian cancer	5.87e-07	1.9e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.8e-07	1.87e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—ovarian cancer	5.74e-07	1.85e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—ovarian cancer	5.41e-07	1.75e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—ovarian cancer	5.38e-07	1.74e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	5.36e-07	1.73e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—ovarian cancer	5.01e-07	1.62e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—ovarian cancer	4.8e-07	1.55e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—ovarian cancer	4.69e-07	1.51e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.58e-07	1.48e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—ovarian cancer	4.42e-07	1.43e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—ovarian cancer	4.38e-07	1.41e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—ovarian cancer	3.74e-07	1.21e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.54e-07	1.14e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—ovarian cancer	2.89e-07	9.33e-06	CbGpPWpGaD
